US FDA's new leaders to focus on restoring credibility and improving transparency
22 May 2009
Sue Sutter
Improving the US
FDA's credibility will be a major focus of the agency's new leadership, principal deputy commissioner Dr
Joshua Sharfstein told a congressional panel on May 21st.
Dr Sharfstein, who is serving as acting commissioner until Dr Margaret Hamburg is sworn in as the agency's permanent...
Please Login to read the full article.
22 May 2009
Sue Sutter
Dr Sharfstein, who is serving as acting commissioner until Dr Margaret Hamburg is sworn in as the agency's permanent...
Please Login to read the full article.
RELATED CONTENT
NEWS
- HHS chief invokes authority to force rejection of broad Plan B OTC sales
- US Capitol Capsule: Use of mind-altering medicines in children, elderly under fire
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- BIO's policy agenda, UK's Blair featured highlights at 2011 biotech conference
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
